[O3–03–01]: FLORTAUCIPIR TAU‐PET SPECIFICITY IS MAINTAINED IN PATIENTS WITH PATHOLOGICALLY CONFIRMED CREUTZFELDT‐JAKOB DISEASE. (1st July 2017) - Day, Gregory S.